Prise en charge de l'hépatite B chronique: un défi en évolution constante [Management of chronic hepatitis B].


Autoria(s): Doerig C.; Antonino A.; Pache I.; Moradpour D.
Data(s)

2010

Resumo

Chronic hepatitis B predisposes to the development of cirrhosis and hepatocellular carcinoma. Treatment of chronic hepatitis B is aimed at halting viral replication and, thereby, hepatic inflammation. Treatment indication should be established carefully and with full knowledge of the advantages and limitations of currently available antiviral drugs. Patients on long-term nudcleos(t)ide analogue treatment should be followed regularly in order to avoid the appearance of antiviral resistance. The purpose of this review is to provide a concise overview of the diagnosis and management of chronic hepatitis B.

Identificador

http://serval.unil.ch/?id=serval:BIB_75EE88E11133

isbn:1660-9379[print], 1660-9379[linking]

pmid:20214187

Idioma(s)

fr

Fonte

Revue Médicale Suisse, vol. 6, no. 233, pp. 168-173

Palavras-Chave #Antiviral Agents/therapeutic use; Drug Resistance, Viral; Genotype; Hepatitis B, Chronic/drug therapy; Hepatitis B, Chronic/genetics; Humans
Tipo

info:eu-repo/semantics/article

article